Live
- DEO suspends teacher accused of sexual assault
- PM ‘cursing’ Congress out of despair: Maharashtra Cong Chief
- Applications are invited for Junior Colleges Scheme District Scheduled Castes Development Officer Ramlal
- A nomination was filed on the second day for the Nagar Kurnool parliamentary seat
- SP Gaikwad inspected the Telangana Amarnath Saleswaram Jatara yatra arrangements
- Rahul Gandhi's decision to contest from Wayanad shows 'lack of confidence': BJP President Nadda
- IPL 2024: Delhi bowlers will go after all of SRH’s top-order batters, says head coach Ricky Ponting
- At Amroha rally, PM Modi sends out ‘meaningful’ message for Muslims and Hindus
- Tripura records highest 79.83 pc voter turnout in Northeast
- The government has to clear the confusion
Oxford, Bharat Biotech vaccines fail to get government nod
Oxford, Bharat Biotech vaccines fail to get government nod
The Serum Institute of India and Bharat Biotech were not granted emergency use authorization (EUA) for their Covid-19 vaccines on Wednesday, sources said, adding that the regulator has sought additional information from the vaccine makers.
New Delhi: The Serum Institute of India and Bharat Biotech were not granted emergency use authorization (EUA) for their Covid-19 vaccines on Wednesday, sources said, adding that the regulator has sought additional information from the vaccine makers.
The SII had earlier applied for EUA for the Oxford-AstraZeneca vaccine which was granted approval in the United Kingdom earlier on Wednesday, while Bharat Biotech had sought the nod for India's indigenous vaccine named Covaxin.
India, which has the world's second highest number of Covid-19 infections in the world after the United States, plans to inoculate 300 million people in the next six to eight months and the affordable Oxford vaccine is its biggest hope.
Though the Union government has not yet signed a purchase agreement with SII, the company says it will focus on its home market first, and then exports, mainly to South Asian countries and Africa.
Earlier in the day, Britain became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca as it battles a major winter surge driven by a new, highly contagious variant of the virus.
The Serum Institute of India (SII) termed the approval for Oxford-AstraZeneca vaccine in the UK as encouraging news and said that the company would now wait for the final nod for the medication in India.
